Uncategorized

IRLAB Therapeutics AB announced that IRLAB has been made aware that Ipsen’s 2022 Universal Registration Document, published on April 6, 2023, contains incorrect information that the development and commercialization rights for mesdopetam have been transferred back to IRLAB.

Occlutech Holding AG is a leading specialist provider of minimally invasive structural heart implants.

Adagio Medical, Inc., a leading innovator in catheter ablation technologies for atrial fibrillation and ventricular tachycardia, announced the completion of enrollment in its Cryocure-VT trial of ultra-low temperature cryoablation for the treatment of monomorphic ventricular tachycardias.

Hyundai Bioscience announced on the 28th that it had received the clinical study report for the COVID-19 phase 2 clinical trial of its antiviral drug ‘Xafty’.

In addition to promoting their brands, companies say their funding initiatives give them access to the expertise of top researchers and contribute to society.

CHS continued to grapple with heightened expenses in the quarter, including a sequential increase in salary and benefit expenses and supply costs, executives said on a Tuesday call.

The medical device maker said it intends to retry the lawsuit, as it awaits a decision from the International Trade Commission on a separate investigation into patent infringement claims against Apple.

With the deal’s completion, CVS adds a multi-state chain of medical clinics for seniors to its primary care roster.

CEO Bryan Hanson said “pretty much everything went better than expected” in the first quarter. 

HHS will start the process to end the requirement, and will make more details available in the coming days, the White House said.